Exegenesis Bio
Company Details
Status: Private
Employees: 101-250
Location:
Hangzhou, Zhejiang Province, China
Type:
sample
Technology:
sample
sample
sample
sample
sample
About: Exegenesis Bio is a clinical stage global gene therapy company with operations in Philadelphia, Boston and China. The company’s innovative gene therapy pipeline is based on proprietary capsids, promoters and unique protein engineering designs.
Two programs have advanced to the clinical stage:
(1) Type I Spinal Muscular Atrophy (SMA) AAV gene therapy in China
(2) neurovascular AMD (wet AMD) rAAV gene therapy in USA
The company has built state-of-the-art cGMP manufacturing facilities that include 500L and 2,000L disposable bioreactors for viral vectors and 30L disposable fermenters for plasmids.
Exegenesis Bio has raised over $150 M since inception in 2019 and currently employs over 200 scientific and operations staff worldwide.
Website: https://www.exegenesisbio.com/
Contacts:
Company Information: Contact@ExegenesisBio.com
Business Development: BD@ExegenesisBio.com
Careers: Careers@ExegenesisBio.com
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Exegenesis Bio | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.